These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Hypernatremia and lactulose therapy. Nelson DC; McGrew WR; Hoyumpa AM JAMA; 1983 Mar; 249(10):1295-8. PubMed ID: 6827705 [TBL] [Abstract][Full Text] [Related]
3. Hypernatremia after the administration of lactulose. Kaupke C; Sprague T; Gitnick GL Ann Intern Med; 1977 Jun; 86(6):745-6. PubMed ID: 869354 [No Abstract] [Full Text] [Related]
4. Pneumatosis coli following treatment with lactulose. Zimmerman AL; Gupta JK; Ingegno AP N Y State J Med; 1979 Nov; 79(12):1896-9. PubMed ID: 292844 [No Abstract] [Full Text] [Related]
5. Lactulose: how many ways can one drug be prescribed? Lukens B; Nierman DM; Schiano TD Am J Gastroenterol; 2011 Sep; 106(9):1726-7. PubMed ID: 21897418 [No Abstract] [Full Text] [Related]
7. Lactulose and severe lactic acidosis. Mann NS; Russman HB; Mann SK; Tsai MF Ann Intern Med; 1985 Oct; 103(4):637. PubMed ID: 3839989 [No Abstract] [Full Text] [Related]
8. Studies of osmotic diarrhea induced in normal subjects by ingestion of polyethylene glycol and lactulose. Hammer HF; Santa Ana CA; Schiller LR; Fordtran JS J Clin Invest; 1989 Oct; 84(4):1056-62. PubMed ID: 2794043 [TBL] [Abstract][Full Text] [Related]
9. Lactulose for hepatic encephalopathy. Med Lett Drugs Ther; 1976 Jan; 18(1):3-4. PubMed ID: 1105127 [No Abstract] [Full Text] [Related]
10. Lactulose: a crucial element in treating hepatic encephalopathy. Gever LN Nursing; 1982 Aug; 12(8):76-8. PubMed ID: 6920588 [No Abstract] [Full Text] [Related]
11. Quiz Page November 2016: Kidney and Neurologic Complications in the Treatment of a Patient With Hepatic Encephalopathy. Pena-Polanco JE; Rondon-Berrios H Am J Kidney Dis; 2016 Nov; 68(5):A15-A17. PubMed ID: 27772635 [No Abstract] [Full Text] [Related]
12. [Comparative study of lactulose and neomycin in the treatment of porto-systemic encephalopathy]. Sala Felis T; Berenguer J; Barrios JM; Gómez J Rev Esp Enferm Apar Dig; 1974 Feb; 42(3):335-42. PubMed ID: 4829021 [No Abstract] [Full Text] [Related]
13. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis. Gluud LL; Vilstrup H; Morgan MY Cochrane Database Syst Rev; 2016 Apr; 4():CD003044. PubMed ID: 27089005 [TBL] [Abstract][Full Text] [Related]
14. Lactitol and lactulose for the treatment of subclinical hepatic encephalopathy in cirrhotic patients. A randomised, cross-over study. Morgan MY; Alonso M; Stanger LC J Hepatol; 1989 Mar; 8(2):208-17. PubMed ID: 2654285 [TBL] [Abstract][Full Text] [Related]
15. Enterococcus lactic acid bacteria strain SF68 and lactulose in hepatic encephalopathy: a controlled study. Loguercio C; Del Vecchio Blanco C; Coltorti M J Int Med Res; 1987; 15(6):335-43. PubMed ID: 3125077 [TBL] [Abstract][Full Text] [Related]
16. [A clinical comparative study of crystalline pure lactulose and powder pure lactitol in portasystemic encephalopathy of cirrhotic patients]. Grandi M; Sacchetti C; Pederzoli S; Celani MF Minerva Gastroenterol Dietol; 1991; 37(4):225-30. PubMed ID: 1805974 [TBL] [Abstract][Full Text] [Related]